Market Place
Sourcing Support
Sonoma Pharma Relaunches Dermatology & Eye Care Lines in U.S.
21 Nov 2024 //
ACCESSWIRE
Sonoma Pharma Receives FDA Clearance for Microcyn® Hydrogel
11 Nov 2024 //
ACCESSWIRE
Sonoma Pharma Reports Q2 FY2025 Financial Results
07 Nov 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals to Exhibit at MEDICA 2024 in Düsseldorf
31 Oct 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Expands Partnership for Wound Care
22 Oct 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Presents At LD Micro Investor Conferences
21 Oct 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Regains Compliance with Nasdaq
19 Sep 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Gets FDA Clearance For OTC Microcyn-Based Solution
17 Sep 2024 //
ACCESSWIRE
Sonoma And EMC Pharma To Co-Market Expanded Eye Care Product Line
11 Sep 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Announces 1-for-20 Reverse Stock Split
28 Aug 2024 //
ACCESSWIRE
Nanocyn Approved By Australian TGA As Effective Against Candida Auris, C-Diff
26 Aug 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Partners For US Distribution Of Wound Care Products
21 Aug 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2025 Financial Results
08 Aug 2024 //
ACCESSWIRE
Sonoma Pharma Celebrates 20 Years In Europe, Adds Ukraine Distributor
09 Jul 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Reports FY And Q4 2024 Financial Results
17 Jun 2024 //
ACCESSWIRE
Sonoma MicrocynAH For Animals At Menards Stores
09 May 2024 //
ACCESSWIRE
Sonoma Expands Negative Pressure Wound Products For US
09 Apr 2024 //
ACCESSWIRE
Sonoma Reports Recent Publication from Australia Highlightings
04 Apr 2024 //
ACCESSWIRE
Sonoma to Present at Trickle Research and LD Micro Investor Conferences
28 Mar 2024 //
ACCESSWIRE
Sonoma Highlights Safety Advantages of its Microcyn Products
27 Mar 2024 //
ACCESSWIRE
Sonoma Pharmaceuticals Reports Third Fiscal Quarter 2024 Financial Results
08 Feb 2024 //
ACCESSWIRE
NovaBay Pharmaceuticals and Sonoma Agree to Market Avenova-branded Products
09 Jan 2024 //
ACCESSWIRE
NovaBay and Sonoma Pharmaceuticals Agree to Market Avenova-branded Products
09 Jan 2024 //
BUSINESSWIRE
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial Results
13 Nov 2023 //
ACCESSWIRE
Sonoma Pharmaceuticals Announces Launch of Next Generation Advanced Solution
03 Nov 2023 //
ACCESSWIRE
Sonoma Announces Pricing of $1.7 Million Public Offering of Common Stock
26 Oct 2023 //
ACCESSWIRE
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2024 Financial Results
10 Aug 2023 //
ACCESSWIRE
Sonoma Announces Appointment of Hye Jin Chung, M.D. to Scientific Advisory Board
03 Aug 2023 //
ACCESSWIRE
Sonoma to Exhibit at Upcoming CPHI North America Conference in Philadelphia
28 Mar 2023 //
ACCESSWIRE
Sonoma Pharmaceuticals and MicroSafe Group Announce New EPA Claims
02 Mar 2023 //
ACCESSWIRE
Sonoma Pharmaceuticals Reports Third Quarter 2023 Financial Results
14 Feb 2023 //
ACCESSWIRE
Sonoma Pharmaceuticals Announces Partnership with Daewoong Pharmaceutical
31 Jan 2023 //
ACCESSWIRE
Sonoma and EMC Announce DoD DAPA Registration for Microcyn(R) Rx Products
26 Jan 2023 //
ACCESSWIRE
Sonoma Launches Two New Products Expanding Its Line of Office Dispense Products
04 Jan 2023 //
ACCESSWIRE
Sonoma Launches Two Dermatological Products for Over-The-Counter Use in the US
27 Oct 2022 //
ACCESSWIRE
Sonoma Pharma to Exhibit at Upcoming CPHI Conference in Frankfurt, Germany
06 Oct 2022 //
ACCESSWIRE
Sonoma Pharmaceuticals Reports First Quarter 2023 Financial Results
11 Aug 2022 //
ACCESSWIRE
Sonoma Pharmaceuticals Launches MicrocynVS(R) Line of Products
02 Aug 2022 //
ACCESSWIRE
Sonoma, MicroSafe Group DMCC add Nanocyn Hospital-Grade Disinfectant to List N
01 Jun 2022 //
BUSINESSWIRE
Sonoma Pharma and MicroSafe Group DMCC Announce EPA Approval for Nanocyn
03 May 2022 //
BUSINESSWIRE
Sonoma Pharma Launches New UTI Product Through Distributors
30 Mar 2022 //
BUSINESSWIRE
Sonoma Pharmaceuticals Reports Third Quarter FY 2022 Financial Results
11 Feb 2022 //
SEEKINGALPHA
Sonoma Pharma Expands its Partner Network for Oral and Dental Products
20 Jan 2022 //
BUSINESSWIRE
Sonoma Pharma to Present at H.C. Wainwright BioConnect Virtual Conference
06 Jan 2022 //
BUSINESSWIRE
Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results
15 Nov 2021 //
BUSINESSWIRE
Sonoma, Dyamed Biotech Partner for New Territories & Products in Southeast Asia
09 Nov 2021 //
BUSINESSWIRE
TGA Approves Sonoma, MicroSafe`s Nanocyn Disinfectant & Sanitizer
15 Oct 2021 //
BUSINESSWIRE
Sonoma Pharmaceuticals Launches Its OTC Products in U.S. and Europe
28 Sep 2021 //
BUSINESSWIRE
Sonoma Pharmaceuticals launches two new dental products.
19 Aug 2021 //
BUSINESSWIRE
Sonoma Pharmaceuticals Reports First Quarter 2022 Financial Results
16 Aug 2021 //
BUSINESSWIRE
Sonoma Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
14 Jul 2021 //
BUSINESS WIRE
Sonoma Pharmaceuticals Reports Fourth Quarter 2021 Financial Results
14 Jul 2021 //
BUSINESS WIRE
Sonoma and EMC Pharma Announce an Exclusive Partnership to Expand Channels
31 Mar 2021 //
BUSINESSWIRE
Sonoma and EMC Pharma Announce an Exclusive Partnership Microcyn®
31 Mar 2021 //
BUSINESSWIRE
Sonoma & TeArai Announce Launch of Two Microcyn technology Products in Australia
09 Sep 2020 //
BUSINESSNEWSWIRE
Sonoma Pharma +8% on launch of two new products in Australia
09 Sep 2020 //
SEEKINGALPHA
